Bandingkan Harga & Kinerja Nusantara Pelabuhan Handal Tbk. (PORT) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Nusantara Pelabuhan Handal Tbk. dan Organon Pharma Indonesia Tbk.: Nusantara Pelabuhan Handal Tbk. diperdagangkan di Rp950 (kapitalisasi pasar 2,57 T, volume 24 jam 42 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Nusantara Pelabuhan Handal Tbk. jauh lebih besar — sekitar 24,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PORT | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 2,57 T | 104,4 M |
Volume | 42 rb | — |
Lot | 420 | — |
Perputaran | 39,75 jt | — |
Harga Rata-rata | 946,45 | — |
Nilai Transaksi | 39,75 jt | — |
Harga Ekuilibrium Indikatif | 940 | — |
Volume Ekuilibrium Indikatif | 3 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Nusantara Pelabuhan Handal Tbk.
PT Nusantara Pelabuhan Handal Tbk (formerly PT Kharisma Mutiara Agung) (the Company) was established dated December 29, 2003 in accordance with Notarial Deed No. 8 of Periasman Effendi, S.H. PT Episenta Utama Investasi is the Company's parent entity which is indirectly controlled by Garibaldi Thohir.
Selengkapnya di halaman PORT →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
